← brief for 2026-11-15 · Slowing decline
Substantial declines in eGFR after initiation of SGLT2-inhibitors associate with increased short-term mortality in hospitalized patients with CKD.
Key takeaways
This study found that a sharp drop in kidney function after starting a common diabetes drug is linked to higher short-term death risk. It was an observational study of hospitalized patients, so it shows a link, not proof of cause. Doctors should watch for this drop closely.
Who did this work
Gao Q · Ma Z · Ren W · Yu Y · Wu L · Zhang Z · Wu Z · Zhou S · Su L · Li Y · Luo F · Lin Y
Source
Article · PubMed, the drug frontier · 2026 Oct 29
https://pubmed.ncbi.nlm.nih.gov/43034494/